NCT03822468
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03822468
Title Study of 2 Ribociclib Doses in Combination With Aromatase Inhibitors in Women With HR+, HER2- Advanced Breast Cancer (AMALEE)
Acronym AMALEE
Recruitment Completed
Gender female
Phase Phase II
Variant Requirements No
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | SWE | LTU | HUN | FRA | FIN | DEU | CZE | CAN | BRA | BGR | BEL | AUT | ARG

Facility Status City State Zip Country Details
Southern Cancer Center PC Mobile Alabama 36608 United States Details
Marin Cancer Care Greenbrae California 94904 United States Details
Rocky Mountain Cancer Centers Longmont Colorado 80501 United States Details
Florida Retina Institute Orlando Florida 32804 United States Details
Weinberg Cancer Institute at FSH Baltimore Maryland 21237-3998 United States Details
Nebraska Hematology Oncology P C Lincoln Nebraska 68506 United States Details
Nebraska Cancer Specialists Omaha Nebraska 68154 United States Details
Comprehensive Cancer Cntr Of Nevada Henderson Nevada 89052 United States Details
New York Oncology Hematology Albany New York 12208 United States Details
Mount Sinai School Of Medicine New York New York 10029 United States Details
Montefiore Medical Center The Bronx New York 10467 United States Details
Millennium Research Clin Develop Houston Texas 77090 United States Details
Texas Oncology McAllen Texas 78503 United States Details
Northwest Medical Specialties Tacoma Washington 98405 United States Details
Novartis Investigative Site San Juan J5402DIL Argentina Details
Novartis Investigative Site Innsbruck Tyrol 6020 Austria Details
Novartis Investigative Site Linz 4010 Austria Details
Novartis Investigative Site Salzburg 5020 Austria Details
Novartis Investigative Site Vienna 1090 Austria Details
Novartis Investigative Site Edegem 2650 Belgium Details
Novartis Investigative Site Namur 5000 Belgium Details
Novartis Investigative Site Natal Rio Grande do Norte 59075 740 Brazil Details
Novartis Investigative Site Florianópolis Santa Catarina 88034 000 Brazil Details
Novartis Investigative Site São Paulo São Paulo 01317 000 Brazil Details
Novartis Investigative Site São Paulo São Paulo 04014-002 Brazil Details
Novartis Investigative Site Goiânia 74605-070 Brazil Details
Novartis Investigative Site São José do Rio Preto 15090 000 Brazil Details
Novartis Investigative Site Plovdiv 4004 Bulgaria Details
Novartis Investigative Site Sofia 1303 Bulgaria Details
Novartis Investigative Site Sofia 1756 Bulgaria Details
Novartis Investigative Site Cambridge Ontario N1R 3G2 Canada Details
Novartis Investigative Site Valledupar Cesar Department 5602310 Colombia Details
Novartis Investigative Site Ibagué Tolima Department 730006 Colombia Details
Novartis Investigative Site Bogotá 110131 Colombia Details
Novartis Investigative Site Bogotá 110221 Colombia Details
Novartis Investigative Site Montería 230002 Colombia Details
Novartis Investigative Site San José 95008 Costa Rica Details
Novartis Investigative Site Brno Czech Republic 656 53 Czechia Details
Novartis Investigative Site Prague 150 06 Czechia Details
Novartis Investigative Site Helsinki 00029 Finland Details
Novartis Investigative Site Tampere FIN-33521 Finland Details
Novartis Investigative Site Besançon 25030 France Details
Novartis Investigative Site Caen 14021 France Details
Novartis Investigative Site Clermont-Ferrand 63011 France Details
Novartis Investigative Site Lyon 08 69373 France Details
Novartis Investigative Site Marseille 13273 France Details
Novartis Investigative Site Montpellier 34298 France Details
Novartis Investigative Site Saint-Herblain 44805 France Details
Novartis Investigative Site Strasbourg F 67085 France Details
Novartis Investigative Site Valenciennes 59300 France Details
Novartis Investigative Site Langen Hesse 63225 Germany Details
Novartis Investigative Site Augsburg 86150 Germany Details
Novartis Investigative Site Berlin 13581 Germany Details
Novartis Investigative Site Bonn 53111 Germany Details
Novartis Investigative Site Dresden 01127 Germany Details
Novartis Investigative Site Dresden 01307 Germany Details
Novartis Investigative Site Essen 45136 Germany Details
Novartis Investigative Site Tübingen 72076 Germany Details
Novartis Investigative Site Weiden 92637 Germany Details
Novartis Investigative Site Budapest H 1122 Hungary Details
Novartis Investigative Site Debrecen 4032 Hungary Details
Novartis Investigative Site Szolnok H-5000 Hungary Details
Novartis Investigative Site Raipur Chhattisgarh 492001 India Details
Novartis Investigative Site Nagpur Maharashtra 441108 India Details
Novartis Investigative Site Bhubaneshwar Odisha 751007 India Details
Novartis Investigative Site Delhii 110 085 India Details
Novartis Investigative Site Mumbai 400 012 India Details
Novartis Investigative Site Amman 11941 Jordan Details
Novartis Investigative Site Kaunas LTU LT 50161 Lithuania Details
Novartis Investigative Site Vilnius LT-08660 Lithuania Details
Novartis Investigative Site Trujillo La Libertad 13011 Peru Details
Novartis Investigative Site San Borja Lima region 41 Peru Details
Novartis Investigative Site San Isidro Lima region 27 Peru Details
Novartis Investigative Site San Miguel Lima region 32 Peru Details
Novartis Investigative Site Lisbon 1400-038 Portugal Details
Novartis Investigative Site Loures 2674514 Portugal Details
Novartis Investigative Site Porto 4200-072 Portugal Details
Novartis Investigative Site Arkhangelsk 163045 Russia Details
Novartis Investigative Site Moscow 111123 Russia Details
Novartis Investigative Site Moscow 115478 Russia Details
Novartis Investigative Site Saint Petersburg 197758 Russia Details
Novartis Investigative Site Cape Town 7500 South Africa Details
Novartis Investigative Site Johannesburg 2196 South Africa Details
Novartis Investigative Site Parktown 2193 South Africa Details
Novartis Investigative Site Stockholm 112 19 Sweden Details
Novartis Investigative Site Stockholm SE-118 83 Sweden Details
Novartis Investigative Site Uppsala 751 85 Sweden Details
Novartis Investigative Site Bangkok 10700 Thailand Details
Novartis Investigative Site Chiang Mai 50200 Thailand Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field